Timothy Hughes, MD, MBBS, FRACP, FRCPA¹, Delphine Rea, MD, PhD², Carla Boquimpani, MD^3*, Yosuke Minami, MD, PhD⁴, Michael Mauro, MD⁵, Jorge E. Cortes, MD⁶, Jane F. Apperley, FRCP, FRCPath, MB⁷, Valentín García Gutiérrez, PhD⁸, Shruti Kapoor, MD^9*, Alex Allepuz, MD, MPH^10*, Sarah Quenet^10*, Yifan Zhang, PhD^9* and Andreas Hochhaus, MD¹¹

¹South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia
²Hôpital Saint-Louis, Paris, France
³HEMORIO, State Institute of Hematology Arthur de Siquiera Cavalcanti, Rio de Janeiro, Brazil
⁴National Cancer Center Hospital East, Kashiwa, Japan
⁵Memorial Sloan Kettering Cancer Center, New York, NY
⁶Georgia Cancer Center, Augusta, GA
⁷Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom
⁸Hematology Service, Hospital Universitario Ramón y Cajal. IRYCIS, Madrid, Spain
⁹Novartis Pharmaceuticals Corporation, East Hanover, NJ
¹⁰Novartis Pharma AG, Basel, Switzerland
¹¹Universitätsklinikum Jena, Jena, Germany

Jane F. Apperley, FRCP, FRCPath, MB¹, Jorge E. Cortes, MD², Elias Jabbour, MD³, Andreas Hochhaus⁴, Timothy Hughes, MD, MBBS, FRACP, FRCPA⁵, Charles Chuah, MD^6*, Hugues de Lavallade, MD^7*, Michael W. Deininger, MD, PhD⁸, Jeffrey H. Lipton, MD, PhD⁹, Elza Lomaia, MD, PhD^10*, Lori Maness, MD¹¹, Michael Mauro, MD¹², James McCloskey, MD^13*, Beatriz Moiraghi, MD^14*, Carolina Pavlovsky^15*, Christine Rojas, MD^16*, Philippe Rousselot, MD, PhD^17*, Tomasz Sacha, MD, PhD^18*, Moshe Talpaz, MD¹⁹, Anna Turkina, MD^20*, Maria Undurraga Sutton^21*, Xiaowei Ren^22*, Alexander Vorog, MD^22* and Gianantonio Rosti^23*

¹Imperial College London, London, United Kingdom
²Georgia Cancer Center, Augusta, GA
³The University of Texas, MD Anderson Cancer Center, Houston, TX
⁴Universitätsklinikum Jena, Jena, Germany
⁵University of Adelaide, Adelaide, Australia
⁶Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore
⁷King's College Hospital NHS Foundation, London, United Kingdom
⁸Versiti Blood Research Institute, Milwaukee, WI
⁹Princess Margaret Cancer Centre, Toronto, ON, Canada
¹⁰Almazov National Medical Research Centre, St. Petersburg, Russian Federation
¹¹University of Nebraska Medical Center, Omaha, NE
¹²Memorial Sloan Kettering, New York, NY
¹³John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ
¹⁴Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina
¹⁵Fundaleu, Buenos Aires, Argentina
¹⁶Centro de Investigaciones Clinicas Vina del Mar, Valparaíso, Chile
¹⁷Centre Hospitalier de Versailles University de Versailles Saint-Quentin-en-Yvelines, Paris, France
¹⁸Jagiellonian University Hospital, Kraków, Poland
¹⁹Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI
²⁰National Medical Research Center for Hematology, Moscow, Russian Federation (Russia), Moscow, Russian Federation
²¹Hospital del Salvador, Santiago, Chile
²²Takeda Development Center Americas, Inc., Lexington, MA
²³IRST/IRCCS “Dino Amadori,”, Meldola (FC), Ravenna, Italy

Victoria A. Vardell, MD¹, Catherine E. Sobieski, MD^1* and Srinivas K. Tantravahi, MBBS²

¹Department of Internal Medicine, University of Utah, Salt Lake City, UT
²Division of Hematology and Hematologic Malignancies, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT

Michael Mauro, MD¹, Alexis Visotcky, MS^2*, Kathryn E Flynn, PhD^3*, Jerald P. Radich, MD⁴, Jay Yang, MD⁵, Vivian Oehler, MD⁴, Jorge E. Cortes, MD⁶, Vamsi K Kota^7*, Srinivas K. Tantravahi, MBBS⁸, Arielle Baim^2*, Mei-Jie Zhang, PhD^9*, Alexander Hinman^10*, Ehab L. Atallah, MD¹¹ and Kendra Sweet, MD¹²

¹Memorial Sloan Kettering Cancer Center, New York, NY
²Medical College of Wisconsin, Milwaukee, WI
³CIBMTR (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI
⁴Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA
⁵Department of Oncology, Wayne State University, Detroit, MI
⁶Georgia Cancer Center Augusta University, Augusta, GA
⁷Georgia Cancer Center, Augusta University, Augusta, GA
⁸Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
⁹Center for International Blood and Marrow Transplant Research, Medical College of Wisconsin, Milwaukee, WI
¹⁰Medical College of Wisconsin, Milwuakee, WI
¹¹Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
¹²Department of Hematology and Oncology, Moffitt Cancer Center, Tampa, FL

Timothy Hughes, MD, MBBS, FRACP, FRCPA¹, Jorge E. Cortes, MD², Naoto Takahashi, MD, PhD³, Richard A. Larson, MD⁴, Ghayas C. Issa, MD⁵, Felice Bombaci^6*, Nicholas Ramscar, MBBS^7*, Shruti Kapoor, MD^8*, Sophie Ifrah^9* and Andreas Hochhaus, MD¹⁰

¹SA Pathology and South Australian Health and Medical Research Institute, University of Adelaide, Adelaide, Australia
²Georgia Cancer Center Augusta University, Augusta, GA
³Department of Hematology, Nephrology, and Rheumatology, Akita University Graduate School of Medicine, Akita, Japan
⁴Section of Hematology/Oncology, University of Chicago, Chicago, IL
⁵Department of Leukemia, Universit Y of Texas At Houston, Houston, TX
⁶Gruppo AIL Pazienti Leucemia Mieloide Cronica, Rome, Italy
⁷Novartis Pharma AG, Basel, Switzerland
⁸Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁹Novartis Pharma AG, Paris, France
¹⁰Univerisitätsklinikum Jena, Jena, Germany

Gunnar Larfors^1*, Hans Lennernäs, PhD^2*, Charlotta Liljebris, PhD^3*, Magnus Brisander, PhD^3*, Gérald Jesson, PhD^3*, Per Andersson, PhD^3* and Leif Stenke, MD, PhD⁴

¹Department of Medical Sciences , Unit of Hematology, Uppsala University, Uppsala, Sweden
²Department of Pharmaceutical Biosciences, Translational Drug Discovery and Development, Uppsala University, Uppsala, Sweden
³Xspray Pharma, Solna, Sweden
⁴Department of Hematology, Theme Cancer and Department of Medicine Solna, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden, Sweden

Matthias Hoch, PhD^1*, Felix Huth, PhD^1*, Ioannis Loisios Konstantinidis, PharmD, PhD^1*, Huijuan Xu, PhD^2*, Yu-Yun Ho, PhD^2*, Francois Pierre Combes, PhD, MSc, PharmD^2*, Florence Hourcade-Potelleret, PhD^3* and Heidi J Einolf, PhD^4*

¹Novartis Institute of Biomedical Research, Basel, Switzerland
²Novartis Pharmaceuticals Corporation, East Hanover, NJ
³Novartis Institute of Biomedical Research, Basel, AL, Switzerland
⁴Novartis Institute of Biomedical Research, East Hanover, NJ

Maria Agustina Perusini^1*, Taehyung Simon Kim^1*, Daniela Žácková, MD, PhD^2*, Katia B Pagnano, MD, PhD³, Jiří Mayer, MD², Carolina Pavlovsky^4*, Ivana Ježíšková, PhD^2*, Anežka Kvetková, MD^2*, Tomáš Jurček, PhD^2*, Beatriz Moiraghi, MD^5*, Ana Ines Varela, MD^5*, Michele Bianchini^6*, Ana Beatriz Pascoal Lopes^3*, Gislaine B O Duarte, MD^3*, Young Seok Yoo, BSc^1*, Carmino Antonio Souza, MD, PhD^3*, Jessie Medeiros^7,8*, Hye Won Lee^1*, Kyoung Ha Kim, MD, PhD⁹, Seong Yoon Yi^1*, Myung Hee Chang^1*, Sagi Abelson, PhD^7,8* and Dennis Dong Hwan Kim, MD, PhD¹

¹Princess Margaret Cancer Centre, University Health Network University of Toronto, Toronto, ON, Canada
²Department of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
³Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
⁴Fundaleu, Buenos Aires, Argentina
⁵Hospital General De Agudos J.M. Ramos Mejia, Buenos Aires, Argentina
⁶CIO-FUCA, Instituto Alexander Fleming, Buenos Aires, Argentina, Buenos Aires, Argentina
⁷Ontario Institute for Cancer Research, Toronto, ON, Canada
⁸Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
⁹Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, SEOUL, South Korea

Emilie Cayssials, MD^1*, Gabriel Etienne, MD, PhD^2*, Ali G Turhan, MD, PhD³, Philippe Rousselot, MD, PhD^4*, Valerie Coiteux, MD^5*, Marc G. Berger, MD, PhD^6*, Francoise Huguet, MD^7* and Agnes Guerci-Bresler, MD, PhD^8*

¹Poitiers University Hospital, Poitiers, France
²Institut Bergonié, Bordeaux, France
³DEPARTMENT OF HEMATOLOGY, Hopital Bicetre-Paris Sud 11 University, Le Kremlin Bicetre, France
⁴Hematology Department, Centre Hospitalier de Versailles, LE CHESNAY CEDEX, France
⁵Hematology Department, CHRU Lille, Lille, FRA
⁶Department of Biological Hematology, University Hospital of Clermont-Ferrand, Clermont-Ferrand, France
⁷Service d'Hematologie, CHU de Toulouse- Institut Universitaire de Cancérologie de Toulouse Oncopole, Toulouse, France
⁸Hematology department, CHU Brabois, Nancy, France

Maria Agustina Perusini^1*, Eshetu G. Atenafu, M.Sc., P.Stat^2*, Donna L. Forrest, MD, FRCPC³, Bence-Bruckler Isabelle^4*, Lynn Savoie, MD^5*, Mary-Margaret Keating, MD, FRCPC⁶, Lambert Busque, MD⁷, Robert Delage, MD^8*, Anargyros Xenocostas, MD, FRCPC⁹, Elena Liew, MD, BSc, FRCPC¹⁰, Pierre Laneuville^11*, Kristjan Paulson¹², Tracy L. Stockley, PhD, FCCMG, FACMG^13*, Jeffrey H. Lipton¹, Brian Leber, MD¹⁴ and Dennis Dong Hwan Kim, MD, PhD¹

¹Princess Margaret Cancer Centre, University Health Network University of Toronto, Toronto, ON, Canada
²Princess Margaret Cancer Centre, Department of Biostatistics, University Health Network, University of Toronto, Toronto, ON, Canada
³Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada
⁴The Ottawa Hospital Research Institute, Ottawa, ON, Canada
⁵University of Calgary, Alberta Health Services, Calgary, AB, Canada
⁶Nova Scotia Health Authority, Halifax, Canada
⁷Division of Hematology-Oncology, CIUSSS de l'Est-de-l'Île-de-Montréal, Hôpital Maisonneuve-Rosemont, Montreal, QC, Canada
⁸Service d hematologie et d oncologie, CHU de Quebec, Hôpital de l'Enfant Jesus, Quebec, QC, Canada
⁹Division of Hematology, Department of Medicine, London Health Sciences Centre, London, ON, Canada
¹⁰University of Alberta Hospital, Edmonton, AB, Canada
¹¹Faculty of Medicine and Health Sciences, McGill University, Montreal, QC, Canada
¹²Max Rady College of Medicine, Rady Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
¹³Advanced Molecular Diagnostics Laboratory, Princess Margaret Cancer Center, Toronto, ON, Canada
¹⁴Division of Hematology and Thromboembolism, Department of Medicine, McMaster University, Hamilton, ON, Canada

Timothy Hughes, MD, MBBS, FRACP, FRCPA¹, Michael Mauro, MD², Susan Branford, PhD³, Wei Deng^4*, Qi Wang^4*, Helen Collins, MD⁵ and Andreas Hochhaus, MD⁶

¹South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia
²Memorial Sloan Kettering Cancer Center, New York, NY
³School of Biological Sciences, SA Pathology, Adelaide, SA, Australia
⁴Enliven Therapeutics, Boulder, CO
⁵Enliven Therapeutics, Windsor, CA
⁶Department of Internal Medicine II, Hematology and Oncology, University Hospital Jena, Jena, Germany

Maria Agustina Perusini^1*, Katia B Pagnano, MD, PhD², Carolina Pavlovsky^3*, Beatriz Moiraghi, MD^4*, Ana Ines Varela, MD^4*, Michele Bianchini^5*, Jiří Mayer, MD⁶, Daniela Žácková, MD, PhD^6*, Anežka Kvetková, MD^6*, Tomáš Jurček, PhD^6*, Ivana Ježíšková, PhD^6*, Ana Beatriz Pascoal Lopes^7*, Gislaine B O Duarte, MD^2*, Carmino Antonio Souza, MD, PhD^2*, Jessie J. F. Medeiros, BSc^8,9, Taehyung Simon Kim^1*, Young Seok Yoo, BSc^1*, Kyoung Ha Kim, MD, PhD¹⁰, Hye Won Lee^1*, Myung Hee Chang^1*, Seong Yoon Yi^1*, Sagi Abelson, PhD^8,9* and Dennis Kim¹

¹Princess Margaret Cancer Centre, University Health Network University of Toronto, Toronto, ON, Canada
²Hematology and Hemotherapy Center, University of Campinas, Campinas, Brazil
³Fundaleu, Buenos Aires, Argentina
⁴Hospital General De Agudos J.M. Ramos Mejia, Buenos Aires, Argentina
⁵CIO-FUCA, Instituto Alexander Fleming, Buenos Aires, Argentina, Buenos Aires, Argentina
⁶Department of Internal Medicine Hematology and Oncology, University Hospital Brno and Masaryk University, Brno, Czech Republic
⁷Hematology and Hemotherapy Center, University of Campinas, Campinas, AC, Brazil
⁸Ontario Institute for Cancer Research, Toronto, ON, Canada
⁹Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada
¹⁰Division of Hematology and Oncology, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, SEOUL, South Korea

Koji Sasaki, MD¹, Michael Mauro, MD², Moshe Yair Levy, MD³, Ehab L. Atallah, MD⁴, Paul B. Koller, MD⁵, Rodrigo Maegawa, MD^6*, Andrea Damon, PhD^6*, Julie Kumar^6*, Mahmudul Khan^6* and Jorge E. Cortes, MD⁷

¹Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
²Memorial Sloan Kettering Cancer Center, New York, NY
³Department of Medical Oncology, Baylor Scott and White Health, Dallas, TX
⁴Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, WI
⁵Department of Hematology/HCT, City of Hope National Medical Center, Duarte, CA
⁶Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁷Georgia Cancer Center, Augusta, GA

Andreas Hochhaus, MD¹, Susanne Saussele, MD ², Francois-Xavier Mahon, MD, PhD³, Virginia Pilipovic, MD^4*, Yifan Zhang, PhD^5*, Peter Schuld, PhD^4* and Tim H. Brümmendorf, MD⁶

¹Univerisitätsklinikum Jena, Jena, Germany
²III. Medizinische Klinik für Hämatologie und Onkologie, Universitätsklinikum Mannheim, Ilvesheim, Germany
³Hematology Department, Institut Bergonié, Bordeaux, France
⁴Novartis Pharma AG, Basel, Switzerland
⁵Novartis Pharmaceuticals Corporation, East Hanover, NJ
⁶Medizinische Klinik IV, Uniklinik RWTH Aachen, Aachen, Germany

Aby Abraham, MD, DM^1*, Hasmukh Jain, MD, DM^2,3,4*, Jina Bhattacharyya, MD, DM^5*, Dubashi Biswajit, MD, DNB, DM^6*, Jayachandran PK, MD, MRCP, DM^7*, Dinesh Bhurani, MD, FRCPA^8*, Stalin Chowdary Bala, MBBS, MD, DM, DNB^9*, Suman Pramanik, MD^10*, Santhosh Devadas^11*, Uday Prakash Kulkarni, MD^1*, Manju Sengar, MD, DM ^2,4,12, Rayaz Ahmed, MD, DM⁸, Thenmozhi Mani, PhD^13*, Damodar Das, MD^14*, Parathan Karunakaran, MD, DM^7*, Sadashivudu Gundeti, MD DM^15*, Rasmi Pallasseri^16*, Nikhil Patkar, MD^4,17,18*, Manjunath Nookala, MD^19*, Smita Kayal, MD, DM^20* and Poonkuzhali Balasubramanian, MSc, PhD¹

¹Department of Haematology, Christian Medical College, Vellore, India
²Adult Hematolymphoid Disease Management Group, Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
³Department of Medical Oncology, Tata Memorial Centre, Mumbai, India
⁴Homi Bhabha National Institute, Mumbai, India
⁵Department of Clinical Hematology, Gauhati Medical College & Hospital, Guwahati, India
⁶Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Puducherry, India
⁷Department of Medical Oncology, Cancer Institute (WIA), Chennai, India
⁸Department of Hemato-Oncology & BMT, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India
⁹Department of Medical Oncology, Nizam's Institute of Medical Sciences, Hyderabad, India
¹⁰Army Hospital (Research & Referral), New Delhi, India
¹¹Department of Medical Oncology, MS Ramaiah Memorial Hospital, Bengaluru, IND
¹²Department of Medical Oncology, Tata Memorial Centre, Mumbai, Maharashtra, India
¹³Department of Biostatistics, Christian Medical College, Vellore, India
¹⁴Department of Haematology, Guwahati Medical College, Guwahati, India
¹⁵Nizam's Institute of Medical Sciences, Hyderabad, India
¹⁶Department of Oncology, MS Ramaiah Medical College, Bengaluru, India
¹⁷Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India
¹⁸Hematopathology Laboratory, ACTREC, Tata Memorial Centre, Navi Mumbai, India
¹⁹Clinical Pharmacology, Advanced Centre for treatment research and education in cancer, Panvel, India
²⁰Department of Haematology, Jawaharlal Institute of Postgraduate Medical Education & Research (JIPMER), Pondicherry, Puducherry, India

Francois Pierre Combes, PhD, MSc, PharmD^1*, Ying Fei Li, PhD^1*, Sherwin K.B. Sy, PhD^1*, Sebastien Lorenzo, MSc^1*, Kohinoor Dasgupta, PhD^2*, Shruti Kapoor, MD^1*, Matthias Hoch, PhD^3* and Yu-Yun Ho, PhD^1*

¹Novartis Pharmaceuticals Corporation, East Hanover, NJ
²Novartis Healthcare Pvt. Ltd, Hyderabad, India
³Novartis Institute of Biomedical Research, Basel, Switzerland

Tomas Radivoyevitch, PhD^1*, Brian J. Druker², Jerry Radich, MD³, Hagop Kantarjian, MD⁴, Wenlong Tang, PhD^5*, Michael J. Hanley, PharmD, PhD^5*, Mingxi M. Song, PhD^5*, Timothy Smith^5* and Dean Bottino, PhD^6*

¹Cleveland Clinic, Cleveland, OH
²Oregon Health & Science University, Portland, OR
³Fred Hutchinson Cancer Center, Seattle, WA
⁴MD Anderson Cancer Center, Houston, TX
⁵Takeda Pharmaceuticals International Co., Cambridge, MA
⁶Takeda Development Center Americas Inc. (TDCA), Lexington, MA

Andrew J. Innes, PhD, FRCPath, MRCP^1,2*, Chloe Hayden, BSc^3*, Victoria Orovboni^4*, David Rees^5*, Simone Claudiani, MD, PhD^1,2*, Fiona Fernando, MBChB^1,2*, Afzal Khan^1,2*, Jennifer Byrne, PhD, FRCPath^6*, Paolo Gallipoli, MD^7,8, Sebastian Francis, MBChB, FRCPath, MD^9*, Mhairi Copland, PhD, MBBChir, FRCP, FRCPath¹⁰, Gillian Horne^10*, Manoj Raghavan, MBBS, PhD, MRCP, FRCPath^11*, Claire Arnold, MD^12*, Angela Collins, MBBS, BSc^13*, Tanya Cranfield, MD^14*, Nicholas Cunningham^12*, Akila Danga, MBBS^15*, Peter Forsyth^16*, Rebecca Frewin^17*, Paula Garland^18*, Guy Hannah^19*, Sandra Hassan^20*, Brian Huntly, MB ChB, FRCPath, FMedSci, PhD²¹, Jissan Husain^22*, Sudhakaran Makkuni^23*, Kate Rothwell^24*, Letizia Foroni, MD, PhD^25*, Jane F. Apperley, FRCP, FRCPath, MB^1,2 and Dragana Milojkovic, FRCPath, PhD^1,2*

¹Centre for Haematology, Faculty of Medicine, Imperial College London, London, United Kingdom
²Department of Haematology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
³North West London Pathology, Imperial College Healthcare NHS Trust, London, United Kingdom
⁴North West London Pathology, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, United Kingdom
⁵Medical School, Faculty of Medicine, Imperial College London, London, United Kingdom
⁶Centre for Clinical Haematology, Nottingham University Hospitals NHS Trust, Nottingham, ENG, United Kingdom
⁷University of Cambridge, London, United Kingdom
⁸Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom
⁹Haematology Department, Sheffield Teaching Hospitals NHS trust, Sheffield, United Kingdom
¹⁰Paul O'Gorman Leukaemia Research Centre, School of Cancer Sciences, University of Glasgow, Glasgow, United Kingdom
¹¹Centre for Clinical Haematology, Queen Elizabeth Hospital, Birmingham, United Kingdom
¹²Belfast City Hospital, Belfast, United Kingdom
¹³Norfolk and Norwich University Hospital, Norwich, United Kingdom
¹⁴Department of Haematology, Queen Alexandra Hospital, Portsmouth, ENG, United Kingdom
¹⁵The Hillingdon Hospital, London, United Kingdom
¹⁶Raigmore Hospial, NHS Highland, Inverness, CA, United Kingdom
¹⁷Department of Haematology, Gloucestershire Royal Hospital, Gloucester, United Kingdom
¹⁸Princess Royal University Hospital, London, United Kingdom
¹⁹Kings College Hospital, London, United Kingdom
²⁰Queens Hospital, Romford, United Kingdom
²¹Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, ENG, United Kingdom
²²Ashford and St Peter's Hospitals NHS Foundation Trust, Chertsey, United Kingdom
²³Mid and South Essex NHS Foundation Trust, Basildon, United Kingdom
²⁴Calderdale and Huddersfield NHS Trust, Huddersfield, United Kingdom
²⁵Centre for Haematology, Department of Immunology and Inflammation, Imperial College London, London, United Kingdom

Vamsi K. Kota, MD¹, Michael W. Deininger, MD, PhD², Jason H. Mendler, MD, PhD³, Wei Shen, PhD^4*, Erinn Hoag Goldman, PhD^5* and Jorge E. Cortes, MD⁶

¹Division of Hematology/Oncology, Georgia Cancer Center at Augusta University, Augusta, GA
²Versiti Blood Research Institute, Milwaukee, WI
³Wilmot Cancer Institute, Division of Hematology and Oncology, University of Rochester Medical Center, Rochester, NY
⁴Pfizer Inc, Groton, CT
⁵Pfizer Inc., New York, NY
⁶Georgia Cancer Center, Augusta, GA

Lynette C.Y. Chee, MBBS, PhD, FRACP, FRCPA^1,2, Nora Lee, MBBS, FRACP, FRCPA^2,3*, Andrew Grigg, MBBS, MD, FRACP, FRCPA^4*, Melissa Chen, MBBS, BMedSc, FRACP, FRCPA^5,6*, Anthony Schwarer, MD⁶, Jeff Szer, MBBS, FRACP^1,2, David T Yeung, MBBS, PhD, BSc, FRACP, FRCPA^7,8, Timothy Hughes, MD, MBBS, FRACP, FRCPA^7,9 and Naranie Shanmuganathan, MBBS, FRACP, FRCPA^10,11

¹Department of Medicine, The University of Melbourne, Parkville, VIC, Australia
²Department of Clinical Haematology, The Royal Melbourne Hospital and Peter MacCallum Cancer Centre, Melbourne, VIC, Australia
³Bendigo Cancer Centre, Bendigo Hospital, Bendigo, VIC, Australia
⁴Department of Clinical Haematology, Austin Health, Heidelberg, VIC, Australia
⁵Monash Haematology, Monash Health, Clayton, VIC, Australia
⁶Department of Haematology, Box Hill Hospital, Box Hill, VIC, Australia
⁷Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, SA, Australia
⁸Precision Cancer Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, Australia
⁹South Australian Health and Medical Research Institute SAHMRI, Adelaide, SA, Australia
¹⁰Department of Haematology, Royal Adelaide Hospital and SA Pathology, Adelaide, Australia
¹¹School of Pharmacy and Medical Science, University of South Australia, Adelaide, SA, Australia